Anette Graven Sams

This inventor holds 15 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: H. Lundbeck A/s, Leo-Pharma A/s. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anette Graven Sams. Retrieved from https://idiyas.com/inventor/anette-graven-sams

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 8)

% Patents Active = 33.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 43(Granted Patents)

Location History:

Vaerloese, DK (2010)
Værlose, DK (2013)
Værløse, DK (2013 - 2017)
Vaerlose, DK (2017 - 2023)

Company Filing History:

Years Active: 2010-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12508239 - Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures (2025-12-30),

2. 12258305 - Alcohol derivatives as Kv7 potassium channel openers (2025-03-25),

3. 11548849 - Alcohol derivatives as KV7 potassium channel openers (2023-01-10),

4. 11434199 - Alcohol derivatives as KV7 potassium channel openers (2022-09-06),

5. 10590067 - Alcohol derivatives of carboxamides as Kv7 potassium channel openers (2020-03-17),

6. 9889122 - Positive allosteric modulators of nicotinic acetylcholine receptor (2018-02-13),

7. 9586961 - Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof (2017-03-07),

8. 9549919 - Positive allosteric modulators of nicotinic acetylcholine receptor (2017-01-24),

9. 9050327 - Positive allosteric modulators of nicotinic acetylcholine receptor (2015-06-09),

10. 9023870 - Positive allosteric modulators of nicotinic acetylcholine receptor (2015-05-05),

11. 8815914 - Positive allosteric modulators of nicotinic acetylcholine receptor (2014-08-26),

12. 8765790 - Positive allosteric modulators of nicotinic acetylcholine receptor (2014-07-01),

13. 8598213 - Positive allosteric modulators of nicotinic acetylcholine receptor (2013-12-03),

14. 8440837 - 2-substituted-ethynylthiazole derivatives and uses of same (2013-05-14),

15. 7674912 - [object Object] (2010-03-09),

Title: Anette Graven Sams: Innovator in Pharmaceutical Chemistry

Introduction

Anette Graven Sams is a distinguished inventor based in Værløse, Denmark. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 14 patents. Her work primarily focuses on the development of novel compounds that activate Kv7 potassium channels, which are crucial for various therapeutic applications.

Latest Patents

Among her latest patents, Anette has developed alcohol derivatives that serve as Kv7 potassium channel openers. These inventions provide novel compounds designed to activate Kv7 potassium channels. Additionally, the patents include pharmaceutical compositions comprising these compounds and their uses in treating disorders responsive to Kv7 channel activation.

Career Highlights

Anette has worked with notable companies in the pharmaceutical industry, including H. Lundbeck A/S and Leo Pharma A/S. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the field of medicinal chemistry.

Collaborations

Anette has collaborated with esteemed colleagues such as Ask Püschl and Jørgen Eskildsen. These partnerships have further enhanced her innovative work and expanded the impact of her inventions.

Conclusion

Anette Graven Sams is a prominent figure in the realm of pharmaceutical innovations, with a strong portfolio of patents that reflect her expertise and dedication to advancing medical science. Her contributions continue to influence the development of new therapeutic solutions.

Profile summary based on public USPTO records.